Loading…
CIK 0001056807 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bvf-inc-il","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $14.7M | 0.6% | 4,561,289 SH | |
| AC IMMUNE SA | SHS | $37.1M | 1.5% | 19,822,436 SH | |
| ALLAKOS INC | COM | $3.8M | 0.2% | 16,552,417 SH | |
| ANNEXON INC | COM | $13.5M | 0.6% | 7,000,000 SH | |
| AVALO THERAPEUTICS INC | COM NEW | $8.3M | 0.3% | 1,036,679 SH | |
| AXSOME THERAPEUTICS INC | COM | $197.1M | 8.0% | 1,690,221 SH | |
| CELCUITY INC | COM | $35.0M | 1.4% | 3,466,000 SH | |
| CIDARA THERAPEUTICS INC | COM NEW | $19.9M | 0.8% | 924,642 SH | |
| CULLINAN THERAPEUTICS INC | COM | $43.5M | 1.8% | 5,750,683 SH | |
| CYTOMX THERAPEUTICS INC | COM | $3.3M | 0.1% | 5,228,461 SH | |
| ELEDON PHARMACEUTICALS INC | COM | $21.3M | 0.9% | 6,293,282 SH | |
| ENGENE HOLDINGS INC | *W EXP 10/31/202 | $605K | 0.0% | 945,402 SH | |
| ESSA PHARMA INC | COM NEW | $13.8M | 0.6% | 8,748,629 SH | |
| FOGHORN THERAPEUTICS INC | COM | $19.4M | 0.8% | 5,302,000 SH | |
| FORTE BIOSCIENCES INC | COM NEW | $4.6M | 0.2% | 594,282 SH | |
| GALAPAGOS NV | SPON ADR | $36.5M | 1.5% | 1,454,422 SH | |
| GH RESEARCH PLC | ORDINARY SHARES | $97.4M | 4.0% | 8,827,712 SH | |
| GLYCOMIMETICS INC | COM | $2.0M | 0.1% | 9,544,262 SH | |
| IKENA ONCOLOGY INC | COM | $5.1M | 0.2% | 4,006,564 SH | |
| IMMUNIC INC | COM | $9.7M | 0.4% | 8,902,972 SH | |
| INVENTIVA SA | ADS | $2.1M | 0.1% | 686,040 SH | |
| IONIS PHARMACEUTICALS INC | COM | $57.7M | 2.4% | 1,913,385 SH | |
| ITEOS THERAPEUTICS INC | COM | $18.4M | 0.7% | 3,075,000 SH | |
| KURA ONCOLOGY INC | COM | $51.2M | 2.1% | 7,754,129 SH | |
| KYMERA THERAPEUTICS INC | COM | $141.3M | 5.8% | 5,161,801 SH | |
| MIRUM PHARMACEUTICALS INC | COM | $126.0M | 5.1% | 2,796,513 SH | |
| MOLECULAR PARTNERS AG | ADS | $5.5M | 0.2% | 1,353,968 SH | |
| MONTE ROSA THERAPEUTICS INC | COM | $26.3M | 1.1% | 5,660,132 SH | |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $771.7M | 31.5% | 19,751,284 SH | |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $1.2M | 0.0% | 59,065 SH | |
| NLS PHARMACEUTICS LTD | COM NEW | $221K | 0.0% | 143,676 SH | |
| OLEMA PHARMACEUTICALS INC | COM | $19.9M | 0.8% | 5,295,893 SH | |
| OVID THERAPEUTICS INC | COM | $1.2M | 0.0% | 3,853,818 SH | |
| PALVELLA THERAPEUTICS INC NE | COM | $19.5M | 0.8% | 696,555 SH | |
| PROTAGONIST THERAPEUTICS INC | COM | $124.5M | 5.1% | 2,575,015 SH | |
| RAPT THERAPEUTICS INC | COM | $11.3M | 0.5% | 9,237,556 SH | |
| REPARE THERAPEUTICS INC | COM | $10.2M | 0.4% | 10,333,600 SH | |
| REVOLUTION MEDICINES INC | COM | $176.2M | 7.2% | 4,982,384 SH | |
| SAB BIOTHERAPEUTICS INC | COM NEW | $1.2M | 0.1% | 917,826 SH | |
| SEPTERNA INC | COM | $25.5M | 1.0% | 4,396,124 SH | |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $30.7M | 1.2% | 1,771,417 SH | |
| TENAX THERAPEUTICS INC | COM NEW | $2.2M | 0.1% | 339,549 SH | |
| THIRD HARMONIC BIO INC | COM | $8.2M | 0.3% | 2,372,933 SH | |
| TSCAN THERAPEUTICS INC | COM | $6.7M | 0.3% | 4,889,474 SH | |
| TYRA BIOSCIENCES INC | COM | $36.7M | 1.5% | 3,944,194 SH | |
| VERASTEM INC | COM NEW | $12.7M | 0.5% | 2,100,468 SH | |
| VERVE THERAPEUTICS INC | COM | $31.6M | 1.3% | 6,904,050 SH | |
| VIGIL NEUROSCIENCE INC | COM | $7.1M | 0.3% | 4,013,633 SH | |
| XENCOR INC | COM | $29.2M | 1.2% | 2,740,141 SH | |
| XOMA ROYALTY CORPORATION | COM NEW | $59.5M | 2.4% | 2,983,026 SH | |
| ZYMEWORKS INC | COM | $51.3M | 2.1% | 4,308,935 SH |
| 13F-HR |
| 0000921895-26-002163 |
| $3.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000921895-25-002281 | $2.80B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000921895-26-001382 | $3.14B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000921895-25-001528 | $2.45B | View |